½ÃÀ庸°í¼­
»óǰÄÚµå
1532525

ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ¼¼°è ¿¹Ãø(2024-2032³â)

Disposable Ureteroscope Market - By Product (Flexible Ureteroscope, Rigid Ureteroscope), By Application (Urolithiasis, Urethral Stricture, Kidney Cancer), By End-use (Hospitals, Ambulatory Surgical Centers) & Global Forecast (2024 - 2032)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 95 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå ±Ô¸ð´Â 2024-2032³â CAGR 17%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¾ö°ÝÇÑ ±ÔÁ¦ °¨¿° °ü¸® ±âÁØÀÌ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÏȸ¿ë ¿ä°ü°æÀº ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ°í »ç¿ë °£ Àçó¸®ÀÇ Çʿ伺À» Á¦°ÅÇÏ¿© ¼ö¼ú °úÁ¤À» °£¼ÒÈ­Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

º´¿ø ¹× Ŭ¸®´ÐÀº ÁøÈ­Çϴ ǥÁØÀ» ÃæÁ·Çϰí ȯÀÚ ¾ÈÀüÀ» °­È­Çϱâ À§ÇØ ÀÌ·¯ÇÑ Àåºñ¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. °¨¿° À§ÇèÀ» ÁÙÀÌ°í ¼º´ÉÀ» Çâ»ó½Ã۱â À§ÇØ Ã·´Ü ¼ÒÀç¿Í µðÀÚÀÎ Çõ½ÅÀ» äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Ç° ¼ö¿ä´Â ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 4¿ù ¿Ã¸²Çª½º´Â °¨¿° °ü¸® ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¿½Ã¿¡ ½Ã¼ú È¿À²À» ³ôÀÌ´Â ÃÖÃÊÀÇ ÀÏȸ¿ë Ç÷º¼­ºí ¿ä°ü°æÀÎ RenaFlex(TM)ÀÇ FDA ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¿ëµµº°·Î´Â ½ÅÀå¾Ï ºÐ¾ßÀÇ ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå °¡Ä¡´Â 2024-2032³â »ó´çÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ÀÇ·á ÀýÂ÷¿¡ ÅëÇյǾî Á¤È®µµ¸¦ ³ôÀ̰í ÀÏȸ¿ë ¼³°è·Î °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ÀÇ·á ÀýÂ÷¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ¿Ü°úÀÇ»çµéÀº ÀÏȸ¿ë ¿ä°ü°æÀ» »ç¿ëÇÏ¿© Àç»ç¿ë °¡´ÉÇÑ ³»½Ã°æÀÇ Àç󸮿¡ µû¸¥ º¹À⼺À» ÇÇÇϸ鼭 Á¾¾çÀ» º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀ¸·Î Á¢±ÙÇϰí Ä¡·áÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½Å¼ÓÇÑ °³¹ßÀº ½ÅÀå¾Ï Ä¡·á¿¡ µµ¿òÀÌ µÇ¾î ½Ã¼ú ½Ã°£À» ´ÜÃàÇϰí ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)(ASCs) ÃÖÁ¾ »ç¿ë ºÎ¹®ÀÇ ÀÏȸ¿ë ¿ä°ü°æ »ê¾÷Àº 2032³â±îÁö »ó´çÇÑ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ½Ã¼ú È¿À²¼º°ú ȯÀÚ ¾ÈÀüÀ» ³ôÀ̱â À§ÇØ ÀÌ·¯ÇÑ È¯°æ¿¡¼­ ÀÏȸ¿ë ¿ä°ü°æ äÅÃÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌµé ¼¾ÅÍ´Â ¼ö¼ú °úÁ¤À» °£¼ÒÈ­ÇÏ°í ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ³»½Ã°æ ±â¼úÀÇ ÃֽйßÀüÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ASC´Â ¾÷¹« ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­Çϰí Àü¹ÝÀûÀΠȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ÀÏȸ¿ë Àåºñ¸¦ ´õ ±¤¹üÀ§ÇÏ°Ô Ã¤ÅÃÇÏ´Â ¹æÇâÀ¸·Î ³ª¾Æ°¡°í ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î À¯·´ÀÇ ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå ±Ô¸ð´Â ÀÇ·á ¼­ºñ½º È®´ë¿Í ºñ´¢±â°ú ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2024-2032³â Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á ±â°üÀº È¿°úÀûÀ̰í À§»ýÀûÀÎ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÏȸ¿ë ¿ä°ü°æÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÏȸ¿ë Àåºñ´Â ºñ´¢±â°ú ÇコÄɾ À§ÇÑ º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ÀÌ ºÐ¾ß¿¡¼­ ´õ ³ªÀº ȯÀÚ °á°ú¿Í °£¼ÒÈ­µÈ ½Ã¼ú °üÇàÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • À§Àå Áúȯ, ¾Ï, ±âŸ ¸¸¼ºÁúȯÀÇ Áõ°¡
      • ÀÏȸ¿ë ³»½Ã°æÀÇ ±â¼úÀû Áøº¸
      • Àúħ½À ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ¿ä°ü°æ °Ë»ç ½Ã¼úÀÇ °íºñ¿ë
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • »óȯ ½Ã³ª¸®¿À
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • GAP ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¿¬¼º ¿ä°ü°æ
  • °æ¼º ¿ä°ü°æ

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¿ä·Î°á¼®Áõ
  • ¿äµµÇùÂø
  • ½ÅÀå¾Ï
  • ±âŸ ¿ëµµ

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASCs)
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • AED.MD
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast
  • Cook Medical
  • Dornier MedTech
  • Karl Storz GmbH
  • NeoScope Inc.
  • Olympus Corporation
  • OPCOM
  • Richard Wolf GmbH
  • Zhuhai Pusen Medical Technology Co., Ltd.
KSA 24.08.21

Disposable Ureteroscope Market size is projected to expand at 17% CAGR from 2024 to 2032, led by stringent regulatory infection control standards. Disposable ureteroscopes are designed to minimize the risk of cross-contamination and streamline the surgical process by eliminating the need for reprocessing between uses.

Hospitals and clinics are adopting these devices to meet the evolving standards and enhance patient safety. Rising incorporation of advanced materials and design innovations to reduce infection risks and improve performance will further add to the product demand. For instance, in April 2024, Olympus announced FDA clearance for RenaFlex(TM), the first single-use flexible ureteroscope that addresses infection control concerns while enhancing procedural efficiency.

The overall market is segregated into product, application, end-use, and region.

Based on application, the disposable ureteroscope market value from the kidney cancer segment is estimated to rise at significant rate from 2024 to 2032. These devices are integrated into medical procedures to enhance precision and minimize infection risks due to their single-use designs. Surgeons are utilizing disposable ureteroscopes to access and treat tumors with greater safety and efficiency whilst avoiding the complexities associated with reprocessing reusable scopes. In addition, rapid developments are helping in kidney cancer treatment for reducing procedure times and enhancing patient outcomes.

Disposable ureteroscope industry from the ambulatory surgical centers (ASCs) end-use segment is anticipated to expand at substantial CAGR up to 2032. This is owing to the increasing adoption of disposable ureteroscopes in these settings to enhance procedural efficiency and patient safety. These centers are incorporating the latest advancements in endoscopic technology to streamline surgical processes and reduce the risk of cross-contamination. This evolution is further driving ASCs towards adopting single-use devices more widely for optimizing operational workflows and improving overall patient outcomes.

Regionally, the Europe disposable ureteroscope market size is projected to depict immense growth between 2024 and 2032, on account of healthcare expansion and the rising prevalence of urological conditions. Healthcare facilities are integrating disposable ureteroscopes to address the growing demand for effective and hygienic diagnostic tools. These single-use devices are providing safer and more efficient solutions for managing urological health and supporting better patient outcomes and streamlined procedural practices in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidences of gastrointestinal disorders, cancer, and other chronic conditions
      • 3.2.1.2 Technological advancements in disposable endoscopes
      • 3.2.1.3 Increasing demand for minimally invasive procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of ureteroscopy procedures
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
  • 3.5 Regulatory landscape
  • 3.6 Technological landscape
  • 3.7 Future market trends
  • 3.8 Value chain analysis
  • 3.9 GAP analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Flexible ureteroscope
  • 5.3 Rigid ureteroscope

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Urolithiasis
  • 6.3 Urethral stricture
  • 6.4 Kidney cancer
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers (ASCs)
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AED.MD
  • 9.2 Becton, Dickinson and Company
  • 9.3 Boston Scientific Corporation
  • 9.4 Coloplast
  • 9.5 Cook Medical
  • 9.6 Dornier MedTech
  • 9.7 Karl Storz GmbH
  • 9.8 NeoScope Inc.
  • 9.9 Olympus Corporation
  • 9.10 OPCOM
  • 9.11 Richard Wolf GmbH
  • 9.12 Zhuhai Pusen Medical Technology Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦